1/31
Vocabulary practice flashcards covering aerosol therapy principles, medication categories, deposition mechanisms, and delivery devices from Egan's Chapter 40.
Aerosol
A suspension of solid or liquid particles in gas.
Bronchodilator
A medication class that dilates the smooth muscle of the airways to open up airways that have become constricted.
Inhaled Corticosteroid
A category of aerosolized medication designed to treat and reduce inflammation in the airways.
Mucus-Controlling Agent
A therapeutic aerosol agent that helps make respiratory mucus easier to expel.
Inhaled Anti-Infective Agent
An aerosolized medication formulated to target and work against viruses and bacteria within the lungs.
Duoneb
A short-acting bronchodilator nebulizer formulation combining albuterol (a SABA) and ipratropium bromide/Atrovent (an anticholinergic).
Combivent
A soft mist inhaler (Respimat) formulation combining the short-acting beta-2 agonist albuterol with the anticholinergic ipratropium bromide.
Thrush (Oral Candidiasis)
A fungal infection caused by Candida albicans in the mouth; prevented by instructing patients to rinse their mouth and spit after using inhaled corticosteroids.
Aerosol Output
The total mass of fluid or drug contained in the aerosol produced by a nebulizer.
Emitted Dose
The mass of drug leaving the mouthpiece of a nebulizer or inhaler as an aerosol.
Mass Median Aerodynamic Diameter (MMAD)
The average particle size in microns where 50% of the particles by mass are smaller and 50% are larger.
Inertial Impaction
The primary deposition mechanism for aerosol particles >5μm, occurring when suspended moving particles collide with surfaces due to mass and velocity, particularly at bifurcations and flow rates >30L/min.

Gravitational Sedimentation
The deposition process wherein aerosol particles settle out of suspension due to gravity; it is the primary mechanism for particles 1–5μm and increases by 10% with a 10-second breath-hold.
Brownian Diffusion
The primary mechanism of deposition for particles <3μm in the alveolar region, driven by random collisions with gas molecules. Particles between 0.5–1μm often remain suspended and exhale without depositing.
Aging (Aerosol)
The process by which an aerosol suspension changes dynamically over time through particles growing, shrinking, coalescing, or falling out via evaporation or hygroscopic water absorption.
Respirgard II Nebulizer
A specialized nebulizer equipped with one-way valves and an expiratory HEPA filter to prevent environmental contamination during the administration of pentamidine.
Baffle
A structural surface inside a nebulizer designed to intercept large aerosol droplets, breaking them down into smaller particles while returning the larger liquid drops to the medication reservoir.

Residual Drug Volume (Dead Volume)
The volume of medication that remains in the small-volume nebulizer at the end of treatment, typically ranging from 0.5mL to more than 2.2mL of a 3mL dose.
Breath-Enhanced Nebulizer
A continuously generating pneumatic jet nebulizer (such as the Pari) that uses vents and one-way valves to increase drug delivery during inspiration and minimize aerosol waste during exhalation.

Breath-Actuated Nebulizer (BAN)
A jet nebulizer (e.g., AeroEclipse) that synchronizes aerosol production only with patient inhalation, increasing the delivered dose threefold and reducing secondhand aerosol exposure.
Small Particle Aerosol Generator (SPAG)
A large-reservoir nebulizer holding 300mL of solution, specifically used in pediatrics to deliver the antiviral ribavirin (Virazole) for Respiratory Syncytial Virus (RSV).

Ultrasonic Nebulizer (USN)
A nebulizer that uses a piezoelectric crystal transducer converting electrical energy into high-frequency acoustic waves to produce a dense aerosol, commonly used for hypertonic saline sputum inductions.

Active Vibrating Mesh Nebulizer
A nebulizer containing an aperture plate with funnel-shaped holes vibrated by a surrounding piezoelectric transducer to produce fine aerosols with low residual volume (0.1–0.4mL).
Passive Vibrating Mesh Nebulizer
A mesh nebulizer that utilizes an ultrasonic horn to push liquid formulation through a stationary mesh to generate aerosol.
Pressurized Metered Dose Inhaler (pMDI)
A compact, multidose device that dispenses uniform medication doses using a canister, propellant, drug formulation, and metering valve.

Priming
The act of shaking and firing a pMDI into the air 1–4 times before initial use or after a prolonged period of non-use (exceeding 2days for HFA inhalers) to ensure correct dosage.
Spacer
A valveless extension tube placed between a pMDI outlet and the mouth to allow the aerosol plume to decelerate and propellants to evaporate, reducing oropharyngeal impaction.
Valved Holding Chamber (VHC)
An accessory device equipped with one-way valves that holds aerosolized medication until inspiration, allowing delivery over multiple tidal breaths and preventing clearance during exhalation.

Soft Mist Inhaler (SMI)
A propellant-free, handheld liquid device (e.g., Respimat) that releases a low-velocity, long-duration aerosol cloud.
Dry Powder Inhaler (DPI)
A breath-actuated delivery device wherein the patient creates an aerosol by inhaling forceful airflow (≥40–60L/min) across finely milled dry powder.
Unit-Dose DPI
A dry powder inhaler device (such as the HandiHaler, Arcapta Neohaler, or Podhaler) that requires the insertion and puncturing of an individual gelatin capsule of medication prior to inhalation.

Continuous Bronchodilator Therapy (CBT)
The administration of continuous albuterol at 10–20mg/hr via a large-volume nebulizer (e.g., HEART or HOPE) for patients presenting with severe, refractory bronchospasm.